{
    "clinical_study": {
        "@rank": "112840", 
        "brief_summary": {
            "textblock": "To evaluate the efficacy of Saquinavir-SGC combination with Zidovudine and Lamivudine in the\n      treatment of HIV-1 infected patients with no previous anti-retroviral drug therapy."
        }, 
        "brief_title": "A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "All enrolled patients will receive the following 3 drug combination: Saquinavir, Zidovudine\n      and Lamivudine. Efficacy and duration of anti-viral response will be evaluated by monitoring\n      of HIV-1 RNA levels. Patients below the detectable limit of 200 copies/ml will be analyzed\n      using the Ultra-direct method with a detection limit of 20 copies/ml. CD4 and CD8 cell\n      counts will also be analyzed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Plasma HIV-1 RNA titers > 10,000 copies/ml.\n\n          -  CD4 cell count > 100 cells/mm3.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with any of the following conditions will be excluded:\n\n          -  Any prior anti-retroviral drug therapy.\n\n        Prior Medication:\n\n        Excluded:\n\n        Previous anti-retroviral drug therapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": "40", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002367", 
            "org_study_id": "229F", 
            "secondary_id": [
                "NR15503", 
                "M61005"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "Saquinavir", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Lamivudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Zidovudine", 
                "Lamivudine", 
                "Reverse Transcriptase Inhibitors", 
                "Saquinavir", 
                "Anti-HIV Agents", 
                "HIV Protease Inhibitors"
            ]
        }, 
        "keyword": [
            "Drug Therapy, Combination", 
            "Acquired Immunodeficiency Syndrome", 
            "Zidovudine", 
            "HIV Protease Inhibitors", 
            "Lamivudine", 
            "Saquinavir", 
            "Reverse Transcriptase Inhibitors", 
            "Anti-HIV Agents"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "AIDS Healthcare Foundation Labs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "Urgent Care Ctr / North Broward Hosp District"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "An Open-Label, Non-Comparative Study of Saquinavir-SGC in Combination With Zidovudine (AZT) and Lamivudine (3TC) in the Treatment of HIV-1 Infected Patients With No Previous Anti-Retroviral Drug Therapy", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002367"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 1997"
    }, 
    "geocoordinates": {
        "AIDS Healthcare Foundation Labs": "34.052 -118.244", 
        "Urgent Care Ctr / North Broward Hosp District": "26.122 -80.143"
    }
}